Elicio Therapeutics
ELTX
ELTX
18 hedge funds and large institutions have $2.48M invested in Elicio Therapeutics in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$98.5K | |
| 2 | +$95.4K | |
| 3 | +$64.7K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.78K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.18K |
Top Sellers
| 1 | -$411K | |
| 2 | -$200K | |
| 3 | -$48.5K | |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$3.52K |